The regulatory ZFAS1/miR-150/ST6GAL1 crosstalk modulates sialylation of EGFR via PI3K/Akt pathway in T-cell acute lymphoblastic leukemia
Abstract Background Noncoding RNAs, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are becoming key parts in the development of multidrug resistance (MDR) in T-cell acute lymphoblastic leukemia (T-ALL). Abnormal expression in sialyated N-glycans have been observed in MDR leukemia. H...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-05-01
|
Series: | Journal of Experimental & Clinical Cancer Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13046-019-1208-x |
id |
doaj-67c94db87f8d41b6adfd4397ea155de0 |
---|---|
record_format |
Article |
spelling |
doaj-67c94db87f8d41b6adfd4397ea155de02020-11-25T02:59:10ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662019-05-0138111510.1186/s13046-019-1208-xThe regulatory ZFAS1/miR-150/ST6GAL1 crosstalk modulates sialylation of EGFR via PI3K/Akt pathway in T-cell acute lymphoblastic leukemiaQianqian Liu0Hongye Ma1Xiuhua Sun2Bing Liu3Yang Xiao4Shimeng Pan5Huimin Zhou6Weijie Dong7Li Jia8College of Laboratory Medicine, Dalian Medical UniversityDepartment of Clinical Laboratory, Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital University of Medicine SciencesDepartment of Medicine Oncology, Second Affiliated Hospital of Dalian Medical UniversityCollege of Laboratory Medicine, Dalian Medical UniversityCollege of Laboratory Medicine, Dalian Medical UniversityCollege of Laboratory Medicine, Dalian Medical UniversityDepartment of Microbiology, Dalian Medical UniversityDepartment of Biochemistry, Dalian Medical UniversityCollege of Laboratory Medicine, Dalian Medical UniversityAbstract Background Noncoding RNAs, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are becoming key parts in the development of multidrug resistance (MDR) in T-cell acute lymphoblastic leukemia (T-ALL). Abnormal expression in sialyated N-glycans have been observed in MDR leukemia. However, the role of sialylation regulated MDR remains poorly understood. The aim of this work is to analyze the alternation of N-glycans in T-ALL MDR. Methods Here, mass spectrometry (MS) is analyzed to screen the N-glycan profiles from ALL cell line CR and adriamycin (ADR)-resistant CR (CR/A) cells. The expression of sialyltransferase (ST) genes in T-ALL cell lines and bone marrow mononuclear cells (BMMCs) of T-ALL patients were analyzed using qRT-PCR. Functionally, T-ALL cell proliferation and MDR are detected through CCK8 assay, colony formation assay, western blot and flow cytometry. RIP assay and Dual-luciferase reporter gene assay confirm the binding association between ZFAS1 and miR-150. Xenograft nude mice models are used to determine the role of ST6GAL1 in vivo. Results Elevated expression of α2, 6-sialyltransferase 1 (ST6GAL1) has been detected. The altered level of ST6GAL1 was corresponding to the drug-resistant phenotype of T-ALL cell lines both in vitro and in vivo. ZFAS1/miR-150/ST6GAL1 axis was existed in T-ALL cell lines. MiR-150 was downregulated and inversely correlated to ST6GAL1 expression. ZFAS1 was a direct target of miR-150 and positively modulated ST6GAL1 level by binding miR-150. ZFAS1/miR-150/ST6GAL1 axis functioned to regulate ADR-resistant cell growth and apoptosis. Besides, EGFR was demonstrated to be a substrate of ST6GAL1, and the sialylated EGFR had an impact on the PI3K/Akt pathway. Conclusion Results suggested that ZFAS1/miR-150/ST6GAL1 axis involves in the progression of T-ALL/MDR further mediates sialylated EGFR via PI3K/Akt pathway. This work might have an application against T-ALL MDR.http://link.springer.com/article/10.1186/s13046-019-1208-xT-ALLST6GAL1miR-150ZFAS1EGFR/PI3K/Akt pathway |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Qianqian Liu Hongye Ma Xiuhua Sun Bing Liu Yang Xiao Shimeng Pan Huimin Zhou Weijie Dong Li Jia |
spellingShingle |
Qianqian Liu Hongye Ma Xiuhua Sun Bing Liu Yang Xiao Shimeng Pan Huimin Zhou Weijie Dong Li Jia The regulatory ZFAS1/miR-150/ST6GAL1 crosstalk modulates sialylation of EGFR via PI3K/Akt pathway in T-cell acute lymphoblastic leukemia Journal of Experimental & Clinical Cancer Research T-ALL ST6GAL1 miR-150 ZFAS1 EGFR/PI3K/Akt pathway |
author_facet |
Qianqian Liu Hongye Ma Xiuhua Sun Bing Liu Yang Xiao Shimeng Pan Huimin Zhou Weijie Dong Li Jia |
author_sort |
Qianqian Liu |
title |
The regulatory ZFAS1/miR-150/ST6GAL1 crosstalk modulates sialylation of EGFR via PI3K/Akt pathway in T-cell acute lymphoblastic leukemia |
title_short |
The regulatory ZFAS1/miR-150/ST6GAL1 crosstalk modulates sialylation of EGFR via PI3K/Akt pathway in T-cell acute lymphoblastic leukemia |
title_full |
The regulatory ZFAS1/miR-150/ST6GAL1 crosstalk modulates sialylation of EGFR via PI3K/Akt pathway in T-cell acute lymphoblastic leukemia |
title_fullStr |
The regulatory ZFAS1/miR-150/ST6GAL1 crosstalk modulates sialylation of EGFR via PI3K/Akt pathway in T-cell acute lymphoblastic leukemia |
title_full_unstemmed |
The regulatory ZFAS1/miR-150/ST6GAL1 crosstalk modulates sialylation of EGFR via PI3K/Akt pathway in T-cell acute lymphoblastic leukemia |
title_sort |
regulatory zfas1/mir-150/st6gal1 crosstalk modulates sialylation of egfr via pi3k/akt pathway in t-cell acute lymphoblastic leukemia |
publisher |
BMC |
series |
Journal of Experimental & Clinical Cancer Research |
issn |
1756-9966 |
publishDate |
2019-05-01 |
description |
Abstract Background Noncoding RNAs, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are becoming key parts in the development of multidrug resistance (MDR) in T-cell acute lymphoblastic leukemia (T-ALL). Abnormal expression in sialyated N-glycans have been observed in MDR leukemia. However, the role of sialylation regulated MDR remains poorly understood. The aim of this work is to analyze the alternation of N-glycans in T-ALL MDR. Methods Here, mass spectrometry (MS) is analyzed to screen the N-glycan profiles from ALL cell line CR and adriamycin (ADR)-resistant CR (CR/A) cells. The expression of sialyltransferase (ST) genes in T-ALL cell lines and bone marrow mononuclear cells (BMMCs) of T-ALL patients were analyzed using qRT-PCR. Functionally, T-ALL cell proliferation and MDR are detected through CCK8 assay, colony formation assay, western blot and flow cytometry. RIP assay and Dual-luciferase reporter gene assay confirm the binding association between ZFAS1 and miR-150. Xenograft nude mice models are used to determine the role of ST6GAL1 in vivo. Results Elevated expression of α2, 6-sialyltransferase 1 (ST6GAL1) has been detected. The altered level of ST6GAL1 was corresponding to the drug-resistant phenotype of T-ALL cell lines both in vitro and in vivo. ZFAS1/miR-150/ST6GAL1 axis was existed in T-ALL cell lines. MiR-150 was downregulated and inversely correlated to ST6GAL1 expression. ZFAS1 was a direct target of miR-150 and positively modulated ST6GAL1 level by binding miR-150. ZFAS1/miR-150/ST6GAL1 axis functioned to regulate ADR-resistant cell growth and apoptosis. Besides, EGFR was demonstrated to be a substrate of ST6GAL1, and the sialylated EGFR had an impact on the PI3K/Akt pathway. Conclusion Results suggested that ZFAS1/miR-150/ST6GAL1 axis involves in the progression of T-ALL/MDR further mediates sialylated EGFR via PI3K/Akt pathway. This work might have an application against T-ALL MDR. |
topic |
T-ALL ST6GAL1 miR-150 ZFAS1 EGFR/PI3K/Akt pathway |
url |
http://link.springer.com/article/10.1186/s13046-019-1208-x |
work_keys_str_mv |
AT qianqianliu theregulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia AT hongyema theregulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia AT xiuhuasun theregulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia AT bingliu theregulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia AT yangxiao theregulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia AT shimengpan theregulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia AT huiminzhou theregulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia AT weijiedong theregulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia AT lijia theregulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia AT qianqianliu regulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia AT hongyema regulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia AT xiuhuasun regulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia AT bingliu regulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia AT yangxiao regulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia AT shimengpan regulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia AT huiminzhou regulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia AT weijiedong regulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia AT lijia regulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia |
_version_ |
1724703924119666688 |